Worth a medium investment for the mid term. A bit later then usual (okt - dec)! It's now low cap season and they are catching up the big ones!
And maybe this was a hint? QUALIGEN THERAPEUTICS INC FILES FOR PROSPECTUS BY THE SELLING STOCKHOLDER OF UP TO 5.2 MILLION SHARES OF COMMON STOCK- SEC FILING Source: (bit.ly/3YXRzb7)
NO investment advise by any means :-). Just a hunch!